Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

C Elfgen, C Leo, RA Kubik-Huch, S Muenst, N Schmidt… - Virchows Archiv, 2023 - Springer
The heterogeneous group of B3 lesions in the breast harbors lesions with different
malignant potential and progression risk. As several studies about B3 lesions have been …

Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis

MN Shehata, H Rahbar, MR Flanagan… - Journal of the American …, 2020 - Elsevier
Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …

High-risk lesions detected by MRI-guided core biopsy: upgrade rates at surgical excision and implications for management

AY Michaels, PS Ginter, K Dodelzon… - American Journal of …, 2021 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of our study was to evaluate the upgrade rates of high-risk lesions
(HRLs) diagnosed by MRI-guided core biopsy and to assess which clinical and imaging …

Lobular neoplasia

L Lunt, A Coogan, CB Perez - Surgical Clinics, 2022 - surgical.theclinics.com
Lobular neoplasia (LN) is a term that describes the continuum of atypical epithelial lesions
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …

Prevalence, impact, and diagnostic challenges of benign breast disease: a narrative review

JL Fraker, CG Clune, SK Sahni, A Yaganti… - … Journal of Women's …, 2023 - Taylor & Francis
Benign breast diseases, which are commonly seen in clinical practice, have various clinical
presentations and implications, as well as management strategies. This article describes …

Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study

IS Genco, B Tugertimur, Q Chang, L Cassell… - Virchows Archiv, 2020 - Springer
Management of classic lobular neoplasia (cLN) diagnosed on core needle biopsy (CNB) is
controversial. Our aim in this study was to review cases of cLN diagnosed on CNB to …

Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution …

L Harinath, TM Villatoro, BZ Clark, JL Fine, J Yu… - Modern Pathology, 2024 - Elsevier
The primary aim of this study was to determine the upgrade rates of variant lobular
carcinoma in situ (V-LCIS, ie, combined florid [F-LCIS] and pleomorphic [P-LCIS]) compared …

[HTML][HTML] Factors indicating surgical excision in classical type of lobular neoplasia of the breast

C Elfgen, C Tausch, AK Rodewald, U Güth, C Rageth… - Breast Care, 2022 - karger.com
Purpose: Classical type of lobular neoplasia (LN) encompassing both atypical lobular
hyperplasia and classical lobular carcinoma in situ of the breast is a lesion with uncertain …

[HTML][HTML] Lobular carcinoma in situ during preoperative biopsy and the rate of upgrade

J Lee, GY Ku, H Lee, HS Park, JS Ku… - … : Official Journal of …, 2022 - synapse.koreamed.org
Purpose There is a potential risk that lobular carcinoma in situ (LCIS) on preoperative biopsy
might be diagnosed as ductal carcinoma in situ (DCIS) or invasive carcinoma in the final …

Upgrade Rate and Long-term Outcomes of Lobular Neoplasia

S Ardila, A Chen, T Maramara, D Henry… - Current Breast Cancer …, 2024 - Springer
Abstract Purpose of Review Lobular neoplasia is a risk factor for breast cancer development,
but its management remains controversial as upgrade rates differ depending on the subtype …